Cadrenal Therapeutics
CVKD
CVKD
17 hedge funds and large institutions have $825K invested in Cadrenal Therapeutics in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
17
Holders Change
+1
Holders Change %
+6.25%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BlackRock
New York
|
+$39.5K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$35.7K |
| 3 |
Raymond James Financial
St Petersburg,
Florida
|
+$23.1K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$7.52K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.64K |
Top Sellers
| 1 |
UBS Group
Zurich,
Switzerland
|
-$97.8K |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
-$14.5K |
| 3 |
Morgan Stanley
New York
|
-$8.44K |
| 4 |
JPMorgan Chase & Co
New York
|
-$1.76K |
| 5 |
PWA
Physician Wealth Advisors
Midvale,
Utah
|
-$917 |
